Quality of Life Grant Cycle Opens September 9, 2020

Posted by Reeve Staff in Daily Dose on September 04, 2020 # News, Quality of Life Grant Spotlight

The Christopher & Dana Reeve Foundation National Paralysis Resource Center announces grant funding opportunities through its 2nd Cycle 2020 Direct Effect Quality of Life (Tier 1) and High Impact Priority Quality of Life (Tiers 2-4) grants initiatives.

Quality of Life (QOL) grants are federally funded through a cooperative agreement with the United States Department of Health and Human Services, Administration for Community Living (ACL) (Cooperative Agreement Number 90PRRC0002-03-00).

Direct Effect QOL grants offer up to $25,000 to nonprofit organizations for projects that clearly impact individuals living with paralysis, their families, and caregivers.

High Impact Priority QOL grants fund projects in the following high-priority areas: Tier 2 – Transportation, Respite/Caregiving, and Disaster Response (grants up to $30,000); Tier 3 – Nursing Home Transition (grants up to $40,000); and Tier 4 – Employment (grants up to $50,000).

The High Impact Priority Employment grants are one of Reeve’s top priorities because employment is fundamental in achieving and maintaining independence while being one of the most challenging obstacles to individuals living with paralysis. In addition, gainful employment allows people living with paralysis to achieve enhanced financial security, higher quality of life, and improved community connections.

Grant funds support programs and projects that:

Assist individuals living with paralysis to enter, re-enter, remain, and advance in the workplace;

Create career pathways to meaningful, living-wage jobs; and

Provide job development services to people living with paralysis, including career education, adaptive technology, and career training with the goal of finding gainful employment.

Grants funds may not provide stipends, and funds may not be given directly to workers or program participants as salaries or other incentives.

Organizations that have previously been awarded a Quality of Life grant in any category may re-apply for funding one year following the close of their grant and notification of grant closure by the Reeve Foundation.

We encourage you to read the updated Application and Program Guidelines, which include new Eligibility Criteria, and to visit the Reeve Foundation website for an overview of the QOL grant program and the QOL grant application process.

A free Application Technical Assistance Webinar will be held on Wednesday, September 16, from 3:00 pm to 4:00 pm ET. You may register HERE or on our website.

QOL grant applications are available and are to be completed online through the Reeve Foundation online grants portal.The online application submission deadline is Thursday, October 22, 2020, at 11:59 pm EASTERN.

The Foundation is no longer able to provide individual pre-award assistance either by telephone or email. However, we welcome you to submit questions about the application process to [email protected]. All questions submitted via email will be collected, aggregated, and answered in a Questions and Answers document posted on our website. The deadline for emailed questions is Monday, September 21.

2020 2nd Cycle Quality of Life Grants Program Calendar

  • Cycle Opens: September 9, 2020
  • Technical Assistance Webinar: September 16, 2020; 3 pm ET. Register HERE
  • Deadline for emailed questions: September 21, 2020 (email to [email protected])
  • Proposals Due: October 22, 2020
  • External Review: October 24 – November 13
  • Internal Review: November 15 – December 9
  • Grants awarded and funded by the end of December 2020
  • Grant period: January 1, 2021 – December 31, 2021

The National Paralysis Resource Center website is supported by the Administration for Community Living (ACL), U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $8,700,000 with 100 percent funding by ACL/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by ACL/HHS, or the U.S. Government.